247-27900-62364
2 vaccinations
2 coded responses
25 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 601 / IL
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-28
Registered in v-safe
-
2021-03-29
Dose 1 — Pfizer-BioNTech
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-06
- 2021-04-12
-
2021-04-19
Dose 2 — Pfizer-BioNTech
-
2021-04-19
Health check-in — day 0, dose 2Feeling: Fair · Site: Redness · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-04-20
Survey response — days 1–6 daily, dose 2MedDRA: Chest pain — Feeling: Poor · Site: Pain · Fever · Headache · Be unable to work, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Chest PainMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-07-19
- 2021-10-18
- 2021-12-21
- 2021-12-27
-
2022-04-19
Survey response — 12 months, dose 2MedDRA: Ovarian cyst — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Ovarian cystMedDRA releases: 2024-11 · check-in free text available
-
2022-04-19
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-29 | Pfizer-BioNTech | |
| 2 | 2021-04-19 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-20 | Unsuccessful | |
| 2022-04-19 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Chest Pain
Release 11 — 12 months, dose 2
Symptoms: Ovarian cyst
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ovarian cyst | · | · | ✓ |
| SRO | Chest pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release